<DOC>
	<DOCNO>NCT01450410</DOCNO>
	<brief_summary>Patients premature ischemic heart disease ( PIHD ) elevate level HDL-C present alter composition high-density lipoprotein ( HDL ) associate loss anti-atherogenic effect arterial endothelium function . Objectives : To analyse treatment nicotinic acid ( NA ) /Laropiprant correct alteration HDL composition endothelial function patient PIHD elevate HDL-C. Methods : A total 46 subject PIHD stable 3 month prior Study , continue treatment statin elevate concentration HDL-C ( HDL-C ≥2.0mmol/L females ≥1.8mmol/L male ) LDL-C &lt; 100mg/dL . This double-blind , randomise Study ; 6 week lifestyle stabilisation , subject treat NA placebo 16 week . At start end treatment , HDL composition study density gradient preparative ultracentrifuge separation FBLC ( fast protein liquid chromatography ) change vasodilation induce endothelium ultrasound . Primary endpoint : change apoA1 content associate treatment . Secondary endpoint : variation change brachial artery diameter reactive hyperaemia change content lipid protein component HDL include apoA2 , paraoxonase , amyloid A LCAT . The change HDL composition endothelial function assess analysis variance repeat measurement 2x2 design .</brief_summary>
	<brief_title>Nicotinic Acid Composition HDL Arterial Endothelium Function Premature Coronary Heart Disease High HDL</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Being male female Age &gt; 25 year Have episode ischemic heart disease 55 year men woman 65 year Serum HDLC 90th percentile Spanish population : &gt; =2.0mmol/L woman &gt; =1.8mmol/L men ( GomezGerique JA , et al . Med Clin ( Barc. ) . 1999 , 113 : 730735 . ) Stable treatment statin past 6 week : simvastatin , atorvastatin , rosuvastatin , pravastatin lovastatin . Uncontrolled hypercholesterolemia hypertriglyceridemia , LDLC &gt; 2.6mmol/L triglyceride &gt; 2.24mmol/L Patients episode ischemic heart disease last 3 month Patients suffer acute chronic inflammatory disease last 3 month Treatment fibrates omega3 fatty acid . Treatment steroid immunosuppressive drug Patients contraindication Tredaptive ( Hypersensitivity active substance excipients , significant unexplained hepatic dysfunction , active peptic ulcer , arterial bleeding ) . Patients treat drug may interact Tredaptive ( Midazolam ) .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Dyslipemia , HDL composition</keyword>
</DOC>